Clinical Trials Logo

Preterm Labor clinical trials

View clinical trials related to Preterm Labor.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT05110599 Terminated - Anxiety Clinical Trials

Bryophyllum Pinnatum Treatment of Anxiety Related to Signs of Preterm Birth

Start date: July 12, 2022
Phase: Phase 2
Study type: Interventional

The present IIT (Investigator-Initiated Trial) study is a prospective, randomised, placebo-controlled, double blind trial. Women hospitalised with signs of preterm birth can be recruited for the study. Participants will take study medication for 2 weeks (or until birth) and fill out a questionnaire at 3 time points (at baseline, after 1 week and after 2 weeks) to assess state of anxiety and sleep quality. Furthermore, information regarding adverse events and the further course of the pregnancy are recorded.

NCT ID: NCT03715530 Terminated - Preterm Birth Clinical Trials

Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women

PAMG-1
Start date: September 2007
Phase: N/A
Study type: Interventional

The study is to evaluate the accuracy of a test device called "PAMG-1" to see if a pregnant women has ruptured membranes in comparison to standardly used testing methods.

NCT ID: NCT02438371 Terminated - Preterm Labor Clinical Trials

Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor

Start date: May 2015
Phase: Phase 4
Study type: Interventional

Tocolytic agents are used for the treatment of preterm labor. It is unclear whether combination treatments of two tocolytic agents are more effective in stopping preterm labor compared to one. Therefore, the investigators propose a comparative effective trial of nifedipine plus indomethacin vs. nifedipine alone for the treatment of preterm labor

NCT ID: NCT02326142 Terminated - Preterm Labor Clinical Trials

A Phase 2 Study of OBE001 Versus Placebo in the Delay of Preterm Birth

TERM
Start date: March 2015
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to assess the efficacy of a single dose of OBE001, an oral oxytocin antagonist, given for up to 7 days to delay preterm birth by 7 days compared to placebo.

NCT ID: NCT00525486 Terminated - Preterm Labor Clinical Trials

Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery

Start date: December 2007
Phase: N/A
Study type: Interventional

To evaluate the treatment efficacy and safety usig extended release nifedipine, as maintenance therapy to pregnant women who were hospitalized and treated for preterm labor until 34 weeks' gestation. After the PTL will stop, we will randomize these women for the treatment group and the control (no treatment) group. The main outcome will be preterm delivery before 34 weeks' gestation. the secondary outcome will be the side effects of the medication and the newborn/mother health variables.